BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/05/2026

FDA Clears Leucovorin Calcium for Approval via ANDAs

The FDA has determined that leucovorin calcium, oral solution, equivalent to 60 milligrams base/vial, was not withdrawn from sale for reasons of safety or effectiveness, paving the way for approval of abbreviated new drug applications (ANDAs) for this medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →